Physician profile
Ryan Mcbride
NPI 1083297220
$581.82
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.58 · 2022: $246 · 2023: $173 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.71 | 2022-2024 | |
| Lilly USA, LLC | $139.47 | 2021-2024 | Mounjaro |
| Pfizer INC. | $81.70 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $69.15 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.88 | 2023 | |
| Amgen INC. | $20.56 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.72 | 2023 | Quviviq |
| Boston Scientific Corporation | $14.31 | 2022 | |
| Mylan Specialty L.P. | $14.31 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.20 | 2022 | |
| Urgo Medical North America, LLC | $13.14 | 2024 | Urgok2 |
| Sunovion Pharmaceuticals INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.